Tiziana Life Sciences Ltd (TLSA) Stock: Why It Increased 4.02%
07/19/2022
05:12
The stock price of Tiziana Life Sciences Ltd (NASDAQ: TLSA) increased by 4.02% in the previous trading session. This is why. The stock price of
Healthcare
>
Biotechnology
>
NASDAQ:
TLSA
Tiziana Life Sciences plc - American Depository Share
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Website: http://www.tizianalifesciences.com
Recent publications about $TLSA
Tiziana Life Sciences Appoints Matthew W. Davis, MD, RPh as Chief Medical Officer and Acting Chief Scientific Officer
07/18/2022
06:00
NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via
Tiziana Life Sciences Announces Resignation of CEO
07/15/2022
16:15
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel
Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice
06/17/2022
16:30
NEW YORK, June 17, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
06/10/2022
08:00
NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel
Tiziana Life Sciences (TLSA) Stock Price: Why It Increased Today
06/09/2022
16:54
The stock price of Tiziana Life Sciences (NASDAQ: TLSA) increased by 0.50% today. This is why. The stock price of Tiziana Life Sciences (NASDAQ: TLSA)
Tiziana Life Sciences PLC (TLSA: NASDAQ) Clinical Improvements for 2nd SPMS Patient
06/09/2022
12:04
Research Note Clinical Results for Second SPMS Patient NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences PLC (NASDAQ: TLSA) announced positive clinical results
Tiziana Life Sciences to Present at the 2022 Biotechnology Innovation Organization Annual Convention to Discuss Recent Updates to Ongoing Clinical Programs
06/06/2022
07:00
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd (NASDAQ: TLSA) (“Tiziana” or the “Company“), a clinical-stage biopharmaceutical company enabling breakthrough immunotherapies
Tiziana Life Sciences Ltd. Announces Annual Report Filed to Regain Nasdaq Compliance
05/24/2022
17:56
NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
04/26/2022
11:43
NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd (NASDAQ: TLSA) (“Tiziana” or the “Company“), a clinical-stage biopharmaceutical company developing alternative routes
SOTD Membership
Customer Service
Privacy Notice | Terms of Use | Sitemap
Copyright © 2022 stocksoftheday.com. Stocks of the Day does not provide investment advice. All rights reserved.
Copyright © 2022 stocksoftheday.com. Stocks of the Day does not provide investment advice. All rights reserved.